How extra calcium in heart cell powerhouses affects mitochondrial heart disease in children
Metabolic Impact and Mechanism of Enhanced Mitochondrial Calcium Uptake in Mitochondrial Cardiomyopathies
This project looks at whether increased calcium entry into mitochondria helps heart cells make more energy in children with mitochondrial cardiomyopathy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State Higher Education System--University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11332250 on NIH RePORTER |
What this research studies
Researchers will examine how mutations that damage mitochondrial energy machinery change a protein channel that controls calcium entry into mitochondria. They found that when Complex I is faulty, cells stop degrading the mitochondrial calcium uniporter, causing more channels to build up and supporting ATP production, and they will study whether this is helpful or harmful for the heart. The team uses fruit flies, mice, and human tissue or sample analyses together with molecular tools like gene-delivery viruses and biochemical assays to trace the pathway. Their goal is to identify molecular steps that could be targeted to protect or improve heart function in affected children.
Who could benefit from this research
Good fit: Children diagnosed with mitochondrial cardiomyopathy or other confirmed mitochondrial oxidative phosphorylation defects (especially involving Complex I) and families willing to provide medical records or tissue/samples would be the most relevant participants for related efforts.
Not a fit: People whose heart disease is not caused by mitochondrial defects, or adults with unrelated forms of cardiomyopathy, are unlikely to receive direct benefit from this research.
Why it matters
Potential benefit: If successful, this work could point to new treatments that help heart cells make more energy and improve heart function and survival for children with mitochondrial cardiomyopathy.
How similar studies have performed: Earlier laboratory work by the team showed the CLIPT mechanism across fruit flies, mice, and humans, but applying these findings to develop treatments for children remains new and unproven.
Where this research is happening
Salt Lake City, United States
- Utah State Higher Education System--University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Chaudhuri, Dipayan — Utah State Higher Education System--University of Utah
- Study coordinator: Chaudhuri, Dipayan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.